Credit Suisse’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-2,489
| Closed | -$440K | – | 3263 |
|
2023
Q1 | $440K | Buy |
2,489
+71
| +3% | +$12.6K | ﹤0.01% | 2802 |
|
2022
Q4 | $935K | Buy |
2,418
+1,087
| +82% | +$420K | ﹤0.01% | 2370 |
|
2022
Q3 | $448K | Buy |
1,331
+8
| +0.6% | +$2.69K | ﹤0.01% | 2835 |
|
2022
Q2 | $435K | Sell |
1,323
-40
| -3% | -$13.2K | ﹤0.01% | 2914 |
|
2022
Q1 | $596K | Sell |
1,363
-15
| -1% | -$6.56K | ﹤0.01% | 2856 |
|
2021
Q4 | $605K | Buy |
1,378
+131
| +11% | +$57.5K | ﹤0.01% | 2898 |
|
2021
Q3 | $694K | Sell |
1,247
-121
| -9% | -$67.3K | ﹤0.01% | 2804 |
|
2021
Q2 | $702K | Buy |
1,368
+238
| +21% | +$122K | ﹤0.01% | 2831 |
|
2021
Q1 | $882K | Sell |
1,130
-256
| -18% | -$200K | ﹤0.01% | 2649 |
|
2020
Q4 | $755K | Buy |
1,386
+444
| +47% | +$242K | ﹤0.01% | 2750 |
|
2020
Q3 | $431K | Sell |
942
-90
| -9% | -$41.2K | ﹤0.01% | 2745 |
|
2020
Q2 | $635K | Buy |
1,032
+382
| +59% | +$235K | ﹤0.01% | 2567 |
|
2020
Q1 | $309K | Sell |
650
-97
| -13% | -$46.1K | ﹤0.01% | 2809 |
|
2019
Q4 | $433K | Buy |
747
+7
| +0.9% | +$4.06K | ﹤0.01% | 3000 |
|
2019
Q3 | $487K | Buy |
740
+212
| +40% | +$140K | ﹤0.01% | 2817 |
|
2019
Q2 | $408K | Sell |
528
-112
| -18% | -$86.5K | ﹤0.01% | 2895 |
|
2019
Q1 | $453K | Sell |
640
-94
| -13% | -$66.5K | ﹤0.01% | 2823 |
|
2018
Q4 | $343K | Buy |
734
+231
| +46% | +$108K | ﹤0.01% | 2933 |
|
2018
Q3 | $434K | Sell |
503
-172
| -25% | -$148K | ﹤0.01% | 2910 |
|
2018
Q2 | $466K | Sell |
675
-170
| -20% | -$117K | ﹤0.01% | 3005 |
|
2018
Q1 | $377K | Sell |
845
-887
| -51% | -$396K | ﹤0.01% | 3071 |
|
2017
Q4 | $763K | Buy |
1,732
+341
| +25% | +$150K | ﹤0.01% | 2710 |
|
2017
Q3 | $687K | Sell |
1,391
-1,116
| -45% | -$551K | ﹤0.01% | 2889 |
|
2017
Q2 | $1.39M | Buy |
+2,507
| New | +$1.39M | ﹤0.01% | 2132 |
|
2017
Q1 | – | Sell |
-435
| Closed | -$145K | – | 3640 |
|
2016
Q4 | $145K | Sell |
435
-23
| -5% | -$7.67K | ﹤0.01% | 3525 |
|
2016
Q3 | $138K | Sell |
458
-268
| -37% | -$80.8K | ﹤0.01% | 3538 |
|
2016
Q2 | $125K | Buy |
726
+201
| +38% | +$34.6K | ﹤0.01% | 3710 |
|
2016
Q1 | $118K | Buy |
+525
| New | +$118K | ﹤0.01% | 3500 |
|
2015
Q4 | – | Sell |
-278
| Closed | -$143K | – | 4082 |
|
2015
Q3 | $143K | Sell |
278
-483
| -63% | -$248K | ﹤0.01% | 3817 |
|
2015
Q2 | $333K | Buy |
761
+78
| +11% | +$34.1K | ﹤0.01% | 3687 |
|
2015
Q1 | $247K | Buy |
+683
| New | +$247K | ﹤0.01% | 3697 |
|
2014
Q4 | – | Sell |
-552
| Closed | -$166K | – | 4288 |
|
2014
Q3 | $166K | Buy |
+552
| New | +$166K | ﹤0.01% | 3796 |
|